Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science|July 5, 2007
Strengthening bioterrorism prevention: global biological materials managementReynolds M Salerno, Lauren T Hickok
Disaster Medicine and Public Health Preparedness|May 5, 2020
Building a Public-Private Partnership to Enhance Laboratory Preparedness and Response in the United StatesReynolds M Salerno, Jasmine Chaitram, Joanne D Andreadis
Open Forum Infectious Diseases|January 14, 2021
SARS-CoV-2 Serologic Assay Needs for the Next Phase of the US COVID-19 Pandemic ResponseAdi V Gundlapalli, Reynolds M Salerno, John T Brooks, et al.
MMWR. Morbidity and Mortality Weekly Report|August 11, 2022
COVID-19 Self-Test Data: Challenges and Opportunities - United States, October 31, 2021-June 11, 2022Matthew D Ritchey, Hannah G Rosenblum, Kim Del Guercio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2021
Advancing Diagnostic Stewardship for Healthcare-Associated Infections, Antibiotic Resistance, and SepsisEmily J Curren, Joseph D Lutgring, Sarah Kabbani, et al.
JMIR Public Health and Surveillance|July 15, 2026
Characteristics Influencing Adherence to SARS-CoV-2 Serial Antigen Testing Following a Federal Safety Communication: Cohort StudyMicajah Z McGarity, Catherine C Pollack, Elizabeth A Currier, et al.
Open Forum Infectious Diseases|August 8, 2024
Pathogen-Agnostic Advanced Molecular Diagnostic Testing for Difficult-to-Diagnose Clinical Syndromes-Results of an Emerging Infections Network Survey of Frontline US Infectious Disease Clinicians, May 2023Preetika S Rao, Diane L Downie, Corinne David-Ferdon, et al.
The Lancet. Public Health|January 4, 2025
The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used over time and their modelled impact on the COVID-19 pandemicSteven Santos, Matthew Humbard, Anastasia S Lambrou, et al.
Health Security|April 12, 2024
Literature Review of Pathogen Agnostic Molecular Testing of Clinical Specimens From Difficult-to-Diagnose Patients: Implications for Public HealthDiane L Downie, Preetika Rao, Corinne David-Ferdon, et al.
Health Security|April 4, 2024
Surveillance for Emerging and Reemerging Pathogens Using Pathogen Agnostic Metagenomic Sequencing in the United States: A Critical Role for Federal Government AgenciesDiane L Downie, Preetika Rao, Corinne David-Ferdon, et al.
Pageof 2